503B Compounding


This interest group brings together industry leaders involved in compounding facilities operating under Section 503B of the FD&C Act. The group will focus on fostering collaboration and dialogue surrounding discussions on emerging regulations, best practices, and navigating the landscape of compliance. Topics covered will include production techniques, personnel practices, facility management, control of materials, and application of GMPs in daily operations ensuring quality for all drug products.

Join this Interest Group
An active PDA membership is required to join an Interest Group. Not a member? Join today.
Interest Group Leaders
Arielle Anahory
Regulatory Compliance Associates Inc.
David Short
QuVa Pharma, Inc
Events and Announcements

More information coming soon.